CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net income (loss)	$ 449,996	$ 1,232,927
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	151,468	162,127
Amortization of debt discount on notes payable	163,769	361,193
Amortization of right of use assets	396,034	987,542
Gain on debt extinguishment	(754,000)	0
Gain (Loss) Related to Litigation Settlement	(632,600)	0
Share-based payment compensation	14,084	11,392
Provision for (recovery of) returns and doubtful accounts	0	70,932
Deferred income taxes (benefit)	12,485	(5,485)
Changes in operating assets and liabilities:
Accounts receivable	541,249	(138,271)
Prepaid expenses and other current assets	271,443	249,383
Contract assets	236,296	432,204
Inventory	0	15,713
Other assets	748,457	(379)
Accounts payable	(53,814)	(571,231)
Accrued expenses and other long-term liabilities	(669,852)	(589,952)
Operating lease liabilities	(524,263)	(1,204,155)
Deferred revenue	(1,058,641)	(1,317,239)
Net cash provided by (used in) operating activities	(707,889)	(303,299)
Cash flows from investing activities:
Purchases of property and equipment	(98,702)	0
Purchase of intangible assets	(10,226)	(63,005)
Net cash provided by (used in) investing activities	(108,928)	(63,005)
Cash flows from financing activities:
Proceeds from public offering, net of underwriting discounts paid	4,181,908	0
Payments of offering costs	(476,143)	0
Proceeds from issuance of PPP loan	0	754,000
Payments of short-term debt	(1,334,058)	(1,000,000)
Net cash provided by (used in) financing activities	2,371,707	(246,000)
Effect of exchange rate changes on cash and cash equivalents	(762)	8,419
Net increase (decrease) in cash and cash equivalents	1,554,128	(603,885)
Cash and cash equivalents, beginning of period	1,920,656	1,475,166
Cash and cash equivalents, end of period	3,474,784	871,281
Supplemental disclosures:
Cash paid for interest	110,408	261,095
Non-cash investing and financing activities:
Accrual of deferred offering costs	19,429	0
Undistributed Series A redeemable convertible preferred stock dividends	848,898	812,362
Accretion of Series A redeemable convertible preferred stock	$ 285,814	$ 366,566